Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk-Reference-Cited by-同舟云学术

Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk

Published:2006-03-03 Issue:5 Volume:49 Page:881-890
ISSN:0012-186X
Container-title:Diabetologia
language:en
Short-container-title:Diabetologia

Author:

,Bingley P. J.,Gale E. A. M.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00125-006-0160-4.pdf

Reference35 articles.

1. Atkinson MA, Eisenbarth GS (2001) Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358:221–229

2. Bingley PJ, for the ICARUS Group (1996) Interactions of age, islet cell antibodies, insulin autoantibodies, and first-phase insulin response in predicting risk of progression to IDDM in ICA+ relatives: the ICARUS data set. Diabetes 45:1720–1728

3. Kulmala P, Savola K, Reijonen H et al (2000) Genetic markers, humoral autoimmunity, and prediction of type 1 diabetes in siblings of affected children. Diabetes 49:48–58

4. The European Nicotinamide Diabetes Intervention Trial (ENDIT) group (2003) Intervening before the onset of type 1 diabetes: baseline data from the European Nicotinamide Diabetes Intervention Trial (ENDIT). Diabetologia 46:339–346

5. The European Nicotinamide Diabetes Intervention Trial (ENDIT) group (2004) European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes. Lancet 363:925–931

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel, high-performance, low-volume, rapid luciferase immunoprecipitation system (LIPS) assay to detect autoantibodies to zinc transporter 8;Clinical and Experimental Immunology;2023-12-27

2. Quantifying beta cell function in the preclinical stages of type 1 diabetes;Diabetologia;2023-09-15

3. Risk Modeling to Reduce Monitoring of an Autoantibody-Positive Population to Prevent DKA at Type 1 Diabetes Diagnosis;The Journal of Clinical Endocrinology & Metabolism;2022-10-13

4. The relationship between GAD65 autoantibody and the risk of T1DM onset;Journal of Diabetes & Metabolic Disorders;2022-08-05

5. Pancreas Islet Cell-Specific Antibody Detection by ELISA;The Journal of Applied Laboratory Medicine;2022-01-01